<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05047809</url>
  </required_header>
  <id_info>
    <org_study_id>TYGH110014</org_study_id>
    <nct_id>NCT05047809</nct_id>
  </id_info>
  <brief_title>The Effect of &quot;Jinchuang Ointment&quot; (JCO) on the Treatment of Wounds in Patients With Hansen's Disease.</brief_title>
  <official_title>The Evaluation of Treatment of Leprosy Wounds With Traditional Chinese Herbal Medicine Complex &quot;Jingchuang Ointment&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lo-Sheng Sanatorium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lo-Sheng Sanatorium</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to evaluate the effect of a Chinese herb complex &quot;Jinchuang ointment&quot; (JCO)&#xD;
      on the treatment of chronic nonhealing wounds in patients with Hansen's disease and its&#xD;
      mechanism.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      20 patients who were hospitalized at Lo-Sheng Sanatorium, Ministry of Health and Welfare,&#xD;
      were recruited. Ulcers were treated in this study using the four-step wound care guidelines,&#xD;
      observation, rinsing, cleaning, and dressing, published by the Taiwan Food and Drug&#xD;
      Administration. Besides, JCO was applied once a day on the wounds.&#xD;
&#xD;
      Basic data of each case were collected, and a monthly wound record was used to follow the&#xD;
      condition of the wound healing of these patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 7, 2021</start_date>
  <completion_date type="Anticipated">March 5, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 5, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The size of wound area</measure>
    <time_frame>Changes in wound size in 3 months</time_frame>
    <description>Length times width</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Leprosy</condition>
  <condition>Hansen's Disease</condition>
  <condition>Wounds</condition>
  <arm_group>
    <arm_group_label>&quot;Jingchuang Ointment&quot;(JCO) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ulcers were treated in this study using the four-step wound care guidelines, observation, rinsing, cleaning, and dressing, published by the Taiwan Food and Drug Administration. Besides, JCO was applied once a day on the wounds, last 3 months.&#xD;
&quot;Jingchuang Ointment&quot; (JCO) is made by Chuang Song Zong Pharmaceutical Co., Ltd. (Taiwan)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regular treatment group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Ulcers were treated in this study using the four-step wound care guidelines, observation, rinsing, cleaning, and dressing, published by the Taiwan Food and Drug Administration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>&quot;Jingchuang Ointment&quot;(JCO)</intervention_name>
    <description>Applied once a day on the wounds</description>
    <arm_group_label>&quot;Jingchuang Ointment&quot;(JCO) group</arm_group_label>
    <other_name>Chuang Song Zong Pharmaceutical Co., Ltd. (Taiwan)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Regular Treatment</intervention_name>
    <description>Do not use the &quot;Jingchuang Ointment&quot;(JCO), as the regular treatment as usual.</description>
    <arm_group_label>Regular treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hanson's patients&#xD;
&#xD;
          -  Meet the definition of chronic wound&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Kidney disease&#xD;
&#xD;
          -  Parathyroid disease&#xD;
&#xD;
          -  Malignant tumors.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei-Hung Hsu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lo-Sheng Sanatorium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hsin-yi Chen</last_name>
    <phone>+886282006600</phone>
    <phone_ext>2506</phone_ext>
    <email>ls01120@lslp.mohw.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lo-Sheng Sanatorium</name>
      <address>
        <city>Taoyuan City</city>
        <zip>33351</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hsin-Yi Chen</last_name>
      <phone>+886282006600</phone>
      <phone_ext>2506</phone_ext>
      <email>ls01120@lslp.mohw.gov.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 25, 2021</study_first_submitted>
  <study_first_submitted_qc>September 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lo-Sheng Sanatorium</investigator_affiliation>
    <investigator_full_name>Hsu Wei Hung</investigator_full_name>
    <investigator_title>Director of chinese medicine</investigator_title>
  </responsible_party>
  <keyword>Leprosy</keyword>
  <keyword>Hansen's disease (HD)</keyword>
  <keyword>Jinchuang Ointment (JCO)</keyword>
  <keyword>wounds</keyword>
  <keyword>anti-inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leprosy</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 30, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/09/NCT05047809/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

